Duo Oncology Inc.
Total raised
$7 M
3 rounds on record
Latest round
$2 M
Jun 2025
First round on record
Feb 2021
Today
Private
No later event on record
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Duo Oncology Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).
SEC Form D · Aug 2026
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Aug 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Duo Oncology Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Jing-Zhou Hou | Executive officer | Aug 2026 |
| Katherine Eichinger | Executive officer | Aug 2026 |
| Sam Rothstein | Executive officer | Aug 2026 |
| Stephen Thorne | Executive officer | Aug 2026 |
| Jing-Zhou Hou | Director | Aug 2026 |
| Joe Gatto | Director | Aug 2026 |
| Lusong Luo | Director | Aug 2026 |
| Sam Rothstein | Director | Aug 2026 |
| Song Li | Director | Aug 2026 |
| Stanley Marks | Director | Aug 2026 |
| Victoria Manax | Director | Aug 2026 |
| Robert Ashley | Director | Aug 2023 |
| Stephen Thorne | Director | Feb 2021 |
| Jing-Zhou Hou | Promoter | Aug 2026 |
| Sam Rothstein | Promoter | Aug 2026 |
| Song Li | Promoter | Aug 2026 |
| Stephen Thorne | Promoter | Aug 2026 |
| Jingjing Sun | Promoter | Aug 2023 |